Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies

被引：0
作者：
Margaret von Mehren
Michael Bookman
Neal J. Meropol
Louis M. Weiner
Eric Sherman
Jinhui Li
Roland Knoblauch
Trilok Parekh
Roger B. Cohen
机构：
[1] Fox Chase Cancer Center,Department of Medical Oncology
[2] US Oncology Research,Arizona Oncology
[3] University Hospitals Case Medical Center,Hematology and Oncology
[4] Seidman Cancer Center,undefined
[5] Georgetown University Medical Center,undefined
[6] Memorial Sloan-Kettering Cancer Center,undefined
[7] Janssen Research & Development,undefined
[8] LLC,undefined
[9] University of Pennsylvania,undefined
[10] Case Comprehensive Cancer Center,undefined
[11] Case Western Reserve University,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 75卷
关键词：
Advanced malignancies; Combination chemotherapy; Docetaxel; Ovarian cancer; Sarcoma; Trabectedin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1047 / 1055
页数：8
相关论文
共 50 条
  • [41] Phase I and pharmacokinetic study of docetaxel combined with melphalan and carboplatin, with autologous hematopoietic progenitor cell support, in patients with advanced refractory malignancies
    Nieto, Y
    Shpall, EJ
    Bearman, SI
    McSweeney, PA
    Cagmoni, PJ
    Matthes, S
    Gustafson, D
    Long, M
    Barón, AE
    Jones, RB
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (04) : 297 - 306
  • [42] A phase I and pharmacokinetic study of the nonpolyglutamatable thymidylate synthase inhibitor ZD9331 plus docetaxel in patients with advanced solid malignancies
    Garry H. Schwartz
    Christopher B. Jones
    Mitchell Garrison
    Amita Patnaik
    Chris Takimoto
    Heather McCreery
    Michael Skinner
    Anthony W. Tolcher
    Eric K. Rowinsky
    Investigational New Drugs, 2004, 22 : 437 - 448
  • [43] A phase I and pharmacokinetic study of the nonpolyglutamatable thymidylate synthase inhibitor ZD9331 plus docetaxel in patients with advanced solid malignancies
    Schwartz, GH
    Jones, CB
    Garrison, M
    Patnaik, A
    Takimoto, C
    McCreery, H
    Skinner, M
    Tolcher, AW
    Rowinsky, EK
    INVESTIGATIONAL NEW DRUGS, 2004, 22 (04) : 437 - 448
  • [44] A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer
    Kim, Kyoung Ha
    Park, Young Suk
    Chang, Myung Hee
    Kim, Hyo Song
    Jun, Hyun Jung
    Uhm, Jieun
    Yi, Seong Yoon
    Lim, Do Hyoung
    Ji, Sang Hoon
    Park, Min Jae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 347 - 353
  • [45] A phase I trial of docetaxel and gemcitabine in patients with advanced cancer
    Rischin, D
    Boyer, M
    Smith, J
    Millward, M
    Michael, M
    Bishop, J
    Zalcberg, J
    Davison, J
    Emmett, E
    McClure, B
    ANNALS OF ONCOLOGY, 2000, 11 (04) : 421 - 426
  • [46] Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I study
    Yang, Jianliang
    Dong, Lihou
    Yang, Sheng
    Han, Xiaohong
    Han, Ying
    Jiang, Shiyu
    Yao, Jiarui
    Zhang, Zhishang
    Zhang, Shuxiang
    Liu, Peng
    Qin, Yan
    Wu, Hai
    Feng, Hui
    Yao, Sheng
    Sun, Yan
    Song, Haifeng
    Shi, Yuankai
    EUROPEAN JOURNAL OF CANCER, 2020, 130 : 182 - 192
  • [47] A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours
    Pronk, LC
    Vasey, P
    Sparreboom, A
    Reigner, B
    Planting, AST
    Gordon, RJ
    Osterwalder, B
    Verweij, J
    Twelves, C
    BRITISH JOURNAL OF CANCER, 2000, 83 (01) : 22 - 29
  • [48] Phase I study of weekly docetaxel and liposomal doxorubicin in patients with advanced solid tumors
    Kouroussis, C
    Androulakis, N
    Vamvakas, L
    Kalykaki, A
    Spiridonakou, S
    Kentepozidis, N
    Saridaki, Z
    Xiropoulou, E
    Georgoulias, V
    ONCOLOGY, 2005, 69 (03) : 202 - 207
  • [49] A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours
    Pronk L.C.
    Vasey P.
    Sparreboom A.
    Reigner B.
    Planting A.S.Th.
    Gordon R.J.
    Osterwalder B.
    Verweij J.
    Twelves C.
    British Journal of Cancer, 2000, 83 (1) : 22 - 29
  • [50] A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer
    Takahashi, Shunji
    Takekuma, Munetaka
    Tamura, Kenji
    Takehara, Kazuhiro
    Nomura, Hiroyuki
    Ono, Makiko
    Yunokawa, Mayu
    Aoki, Daisuke
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (10) : 1977 - 1985
12345